Table 1 Patients’ characteristics
Characteristic | Total |
|---|---|
N | 51 |
Sections containing nodular calcification | 49 (96) |
Sections containing sheet calcification | 48 (94.1) |
Average nodular calcification area proportion (%) | 22.4 ± 12.3 |
Average sheet calcification area proportion (%) | 14.5 ± 11.8 |
Age (years) (N = 51) | 70.5 ± 6.9 |
Risk factors | |
Sex: male | 28 (54.9) |
Diabetes type I or II | 14 (28.6) |
Hypertension | 43 (84.3) |
Dyslipidemia | 45 (88.2) |
Increased hs-CRPa | 13 (25.5) |
BMI = 25–30 (kg/m2) | 18 (35.3) |
BMI > 30 | 11 (21.6) |
Smoking status (N = 49) | |
Never | 2 (4.0) |
Current smoker | 28 (54.9) |
Ex- smoker | 19 (37.3) |
Co-morbidities | |
Coronary artery disease (N = 49) | 12 (24.5) |
Cerebrovascular disease | 3 (6.1) |
Medications | |
ACE inhibitors / AT blockers | 38 (74.5) |
Aspirin | 36 (70.6) |
Clopidogrel | 7 (13.7) |
Statins | 38 (74.5) |
Warfarin | 3 (5.9) |
Lab parameters | |
Hemoglobin (g/L) (N = 50) | 139.0 ± 13.9 |
Total leukocyte count (10E9/L) (N = 50) | 7.9 ± 1.8 |
Thrombocytes (10E9/L) (N = 50) | 267.2 ± 65.6 |
Total cholesterol (mmol/L) | 4.3 ± 1.3 |
LDL-cholesterol (mmol/L) (N = 50) | 2.1 ± 0.8 |
HDL-cholesterol (mmol/L) | 1.3 ± 0.5 |
Triglycerides (mmol/L) | 1.8 ± 2.3 |
LEAD symptoms severity (Fontaine class) | |
Claudication (II, IIA, IIB) | 34 (66.6) |
Rest pain (III) | 12 (23.5) |
Ischemic ulcer or gangrene (IV) | 5 (9.8) |
Classification of the intervention | |
Semiurgent operation | 9 (17.6) |
Elective operation | 42 (82.4) |
TP readings (N = 43) | |
TP < 30 mmHg | 12 (72.1) |
TP ≥ 30 mmHg | 31 (27.9) |
ABI (N = 41) | |
ABI < 0.4 | 19 (45.2) |
ABI ≥ 0.4 | 23 (54.8) |